The 2nd Annual Next Generation Cancer Vaccine Development Summit will focus on overcoming the translational and clinical challenges of therapeutic and prophylactic vaccines for oncology indications.
Attend our presentation
Is there a single “best” platform or will it be “fit to purpose”?
Time: 10:00am EST
Day: August 18, 2022
Speaker: Jeffrey Bockman, PhD, EVP, BioConsulting, Head of Oncology, Lumanity
Details:
- Analyzing the advantages, disadvantages and comparisons of the DNA, Peptide, RNA, and Virus-based and other novel vaccine platforms
- Harmonization of clinical outcomes and immune correlates
- Considering if we can we get better at predictive animal models?
- Questioning what other signals we need to provide to the immune system, either built into the vaccine or given concomitantly (checkpoints, costims, cytokines, innate immunity boosters, etc.)
Click here to register!